Shanghai, China

Xiaoyu He

This inventor holds 2 USPTO granted patents. Top assignee: Tongji University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoyu He. Retrieved from https://idiyas.com/inventor/xiaoyu-he-2ofzqbnl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Treatment by Xiaoyu He

Introduction

Xiaoyu He is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of cardiology through his innovative research and patent applications. His work focuses on the use of heterocyclic derivatives for the treatment of heart diseases.

Latest Patents

Xiaoyu He holds a patent titled "Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases." This patent details the use of compounds of a specific formula, which includes pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs. The compounds are designed to promote cardiomyocyte proliferation, offering a potential therapeutic avenue for heart disease treatment.

Career Highlights

Xiaoyu He is affiliated with Tongji University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cardiac health and treatment methodologies. He has successfully secured a patent that underscores his innovative approach to addressing heart diseases.

Collaborations

Xiaoyu He collaborates with notable colleagues, including Yihan Chen and Dandan Liang. Their combined expertise contributes to the advancement of research in cardiology and the development of new therapeutic strategies.

Conclusion

Xiaoyu He exemplifies the spirit of innovation in the medical field, particularly in cardiac treatment. His patent and ongoing research hold promise for improving heart disease therapies and enhancing patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…